Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
Phase 1Safety & dosage
1(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (100.0%)

Trials by Status

withdrawn125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completed

STigma and Its Impact on Glucose Control aMong Youth With diAbetes, a Canada-Wide Study

NCT02796248
completed

Acceptance of Complementary Medicine in Germany

NCT05530720
completed

Effects of Integrative Medicine on Infectious Respiratory Diseases Including COVID-19

NCT04653727
withdrawnphase_1

HIV Educational Programs for Villagers of Funan County or Yingzhou District, Anhui Province, China

NCT00068991

Clinical Trials (4)

Showing 4 of 4 trials
NCT02796248

STigma and Its Impact on Glucose Control aMong Youth With diAbetes, a Canada-Wide Study

Completed
NCT05530720

Acceptance of Complementary Medicine in Germany

Completed
NCT04653727

Effects of Integrative Medicine on Infectious Respiratory Diseases Including COVID-19

Completed
NCT00068991Phase 1

HIV Educational Programs for Villagers of Funan County or Yingzhou District, Anhui Province, China

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4